Article

Targeting Fyn kinase for alleviation of cognitive impairment in Streptozocin-induced Alzheimer’s disease in mice by Loperamide; An Experimental and In silico analysis

2025-04-03

Abstract excerpt

<title>Abstract</title> <p>Alzheimer’s disease (AD) is a complex, progressive neurodegenerative disorder that leads to irreversible deterioration of neuronal cells over time. It is the most frequent cause of dementia in elderly individuals globally. Current treatment drugs exhibit a modest effect on AD patients. Fyn kinase is implicated in AD pathogenesis, and its interactions with both AD hallmarks Aβ and tau ma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bafad2bd-6e4f-5fe0-8570-09507f1f290c
DOI: 10.21203/rs.3.rs-6268540/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeting Fyn kinase for alleviation of cognitive impairment in Streptozocin-induced Alzheimer’s disease in mice by Loperamide; An Experimental and In silico analysisDOI 10.21203/rs.3.rs-6268540/v1Read

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative PathwaysSemantic proximity Read

African Natural Products for Multitarget-Based Treatment of Alzheimer’s Disease: An In Silico StudySemantic proximity Read

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug DevelopmentSemantic proximity Read

Polyphenols in the Pipeline: Network-Based Docking, Molecular Dynamics and ADMET Studies of Flavonoids against Alzheimer’s diseaseSemantic proximity Read

Gomisin N rescues cognitive impairment of Alzheimer's disease by targeting GSK3β and activating Nrf2 signaling pathwaySemantic proximity Read

Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formationSemantic proximity Read

Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?Semantic proximity Read

DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's DiseaseSemantic proximity Read

Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.Semantic proximity Read

Multi-scale predictive modeling discovers Ibudilast as a polypharmacological agent to improve hippocampal-dependent spatial learning and memory and mitigate plaque and tangle pathology in a transgenic rat model of Alzheimer’s diseaseSemantic proximity Read

Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model.Semantic proximity Read

Fyn Kinase in Brain Diseases and Cancer: The Search for InhibitorsSemantic proximity Read